Atlantic American Corporation Reports Third Quarter Results for 2025
Atlantic American Corporation (Nasdaq: AAME) reported net income of $0.6M (diluted $0.02) for Q3 2025 and net income of $4.7M (diluted $0.22) for the nine months ended September 30, 2025, versus net losses in comparable 2024 periods. Premium revenue rose nearly 12% year-to-date, driven by automobile liability, inland marine, automobile physical damage, Medicare supplement and group accident and health lines.
Operating income increased by $2.3M in Q3 and $7.7M year-to-date. Unrealized gains on equity securities contributed to results. Selected balance-sheet metrics: total assets $430.9M, cash and investments $289.5M, shareholders' equity $109.5M, book value per share $5.10.
Atlantic American Corporation (Nasdaq: AAME) ha riportato un utile netto di $0.6M (diluito $0.02) per il III trimestre 2025 e un utile netto di $4.7M (diluito $0.22) per i primi nove mesi conclusi al 30 settembre 2025, rispetto a perdite nette nei periodi comparabili del 2024. I ricavi da premi sono aumentati di quasi 12% da inizio anno, trainati dalle linee di responsabilità civile automobilistica, marine interne, danni fisici auto, Medicare supplement e assicurazione salute e infortuni di gruppo.
Il margine operativo è aumentato di $2.3M nel trimestre e di $7.7M da inizio anno. Guadagni non realizzati su strumenti azionari hanno contribuito ai risultati. Indicatori selezionati di bilancio: attività totali $430.9M, liquidità e investimenti $289.5M, patrimonio netto degli azionisti $109.5M, valore contabile per azione $5.10.
Atlantic American Corporation (Nasdaq: AAME) reportó ingresos netos de $0.6M (diluido $0.02) para el tercer trimestre de 2025 y ingresos netos de $4.7M (diluido $0.22) para los primeros nueve meses terminados el 30 de septiembre de 2025, frente a pérdidas netas en periodos comparables de 2024. Los ingresos por primas aumentaron casi un 12% año a la fecha, impulsados por responsabilidad civil de automóviles, marina interior, daños físicos de vehículos, Medicare supplement y líneas de salud y accidente en grupo.
El ingreso operativo aumentó en $2.3M en el trimestre y $7.7M acumulados. Las ganancias no realizadas en valores de capital aportaron a los resultados. Métricas seleccionadas del balance: activos totales $430.9M, efectivo e inversiones $289.5M, patrimonio neto de los accionistas $109.5M, valor contable por acción $5.10.
Atlantic American Corporation (Nasdaq: AAME)는 2025년 3분기에 순이익 $0.6M (희석주당 $0.02), 2025년 9개월 동안의 순이익 $4.7M (희석주당 $0.22)을 보고했으며, 비교 가능한 2024년 기간의 순손실 대비 증가했습니다. 프리미엄 매출은 거의 연간 누적 12%로 상승했고, 이는 자동차 책임보험, Inland Marine, 자동차 물적손해, Medicare 보장 보충 및 그룹 사고 및 건강보험 라인에 의해 주도되었습니다.
영업이익은 3분기에 $2.3M, 연간 누적 $7.7M 증가했습니다. 주식자본의 미실현 이익이 실적에 기여했습니다. 대차대조표의 선택 지표: 총자산 $430.9M, 현금 및 투자 $289.5M, 주주자본 $109.5M, 주당 순자산가치 $5.10.
Atlantic American Corporation (Nasdaq: AAME) a déclaré un bénéfice net de $0.6M (dilué $0.02) pour le T3 2025 et un bénéfice net de $4.7M (dilué $0.22) pour les neuf mois terminés le 30 septembre 2025, contre des pertes nettes dans des périodes comparables de 2024. Les revenus de primes ont presque augmenté de 12% en rythme annuel, tirés par la responsabilité automobile, l’inland marine, les dommages matériels automobiles, le Medicare supplement et les lignes d’assurance maladie et accidents collectifs.
Le résultat opérationnel a augmenté de $2.3M au T3 et de $7.7M en cumul sur l’année. Des gains non réalisés sur des valeurs mobilières ont contribué aux résultats. Indicateurs sélectionnés du bilan : actifs totaux $430.9M, trésorerie et placements $289.5M, capitaux propres des actionnaires $109.5M, valeur comptable par action $5.10.
Atlantic American Corporation (Nasdaq: AAME) meldete ein Nettoeinkommen von $0.6M (verwässert $0.02) für das Q3 2025 und ein Nettoeinkommen von $4.7M (verwässert $0.22) für die in den neun Monaten bis zum 30. September 2025 abgeschlossenen Periode, im Vergleich zu Nettolosen in vergleichbaren Perioden 2024. Die Prämienerlöse stiegen fast um 12% year-to-date, getrieben von Autoversicherungs-Haftpflicht, Inland Marine, Autoprodukt-Schäden, Medicare-Versorgungsergänzungen und Gruppenunfall- und Krankenversicherungslinien.
Das Betriebsergebnis stieg im Q3 um $2.3M und year-to-date um $7.7M. Nicht realisierte Gewinne aus Aktienwerten trugen zu den Ergebnissen bei. Ausgewählte Bilanzkennzahlen: Gesamtvermögen $430.9M, Bargeld und Investitionen $289.5M, Eigenkapital der Aktionäre $109.5M, Buchwert je Aktie $5.10.
Atlantic American Corporation (Nasdaq: AAME) أبلغت عن صافي دخل قدره $0.6M (مخففاً 0.02 دولار) للربع الثالث من 2025 وصافي دخل قدره $4.7M (مخففاً 0.22 دولار) لل التسعة أشهر المنتهية في 30 سبتمبر 2025، مقابل خسائر صافية في فترات 2024 المماثلة. ارتفع إيراد الأقساط بنحو 12% منذ بداية العام حتى التاريخ، مدفوعاً بمسؤولية السيارات، واللاين مارين Inland Marine، وأضرار السيارات الفعلية، وتكميل ميديكير وخطوط التأمين الصحي الجماعي والتأمين ضد الحوادث.
ارتفع الدخل التشغيلي بمقدار $2.3M في الربع الثالث وبمقدار $7.7M منذ بداية العام حتى التاريخ. ساهمت الأرباح غير المحققة في الأوراق المالية في النتائج. مقاييس الميزانية المختارة: الأصول الإجمالية $430.9M، النقد والاستثمارات $289.5M، حقوق المساهمين $109.5M، القيمة الدفترية للسهم $5.10.
- Net income $4.7M for nine months ended Sept 30, 2025
- Premium revenue nearly +12% year-to-date
- Operating income +$7.7M nine months, +$2.3M Q3
- Book value per share increased to $5.10 from $4.61
- Income tax expense $1.3M nine months 2025 versus benefit ($1.1M) in 2024
Insights
Atlantic American turned to profitability in 2025, driven by higher premiums and investment mark‑to‑market gains.
The company’s core mechanism is underwriting and investment income across its life, health and property & casualty businesses. Premiums rose to
Key dependencies and risks tie directly to items the company disclosed: results rely on sustained premium growth, claim experience in property & casualty and life & health lines, reinsurance performance, and investment valuation swings — the press release notes unrealized equity gains materially affected results and lists macroeconomic, regulatory and cybersecurity risks. These factors can quickly change quarterly operating income and statutory capital.
Concrete items to watch over the next few quarters: sequential premium growth and retention rates, quarterly operating income versus net income (to separate core underwriting from unrealized investment effects), unrealized gains/(losses) on equity securities, and statutory capital/book value (current book value per share
ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net income of
Operating income increased
Commenting on the results, Hilton H. Howell, Jr., Chairman, President and Chief Executive Officer, stated, “We are excited to share that Atlantic American delivered strong year-to-date results, with net income of
Atlantic American Corporation is an insurance holding company involved through its subsidiary companies in specialty markets of the life, health, and property and casualty insurance industries. Its principal insurance subsidiaries are American Southern Insurance Company, American Safety Insurance Company, Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company.
Note regarding non-GAAP financial measure: Atlantic American Corporation presents its consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP). However, from time to time, the Company may present, in its public statements, press releases and filings with the Securities and Exchange Commission, non-GAAP financial measures such as operating income (loss). We define operating income (loss) as net income (loss) excluding: (i) income tax expense (benefit); (ii) realized investment (gains) losses, net; and (iii) unrealized (gains) losses on equity securities, net. Management believes operating income (loss) is a useful metric for investors, potential investors, securities analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as income tax expense (benefit), which is subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operating results (such as any realized and unrealized investment gains (losses), which are not a part of the Company’s primary operations and are, to a limited extent, subject to discretion in terms of timing of realization). The financial data attached includes a reconciliation of operating income (loss) to net income (loss), the most comparable GAAP financial measure. The Company’s definition of operating income (loss) may differ from similarly titled financial measures used by others. This non-GAAP financial measure should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.
Note regarding forward-looking statements: Except for historical information contained herein, this press release contains forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those indicated by such forward-looking statements due to a number of factors and risks, including, among others: the effects of macroeconomic conditions and general economic uncertainty; unexpected developments in the health care or insurance industries affecting providers or individuals, including the cost or availability of services, or the tax consequences related thereto; disruption to the financial markets; unanticipated increases in the rate, number and amounts of claims outstanding; the level of performance of reinsurance companies under reinsurance contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses; changes in the stock markets, interest rates or other financial markets, including the potential effect on the Company’s statutory capital levels; the uncertain effect on the Company of regulatory and market-driven changes in practices relating to the payment of incentive compensation to brokers, agents and other producers; the potential impact of public health emergencies; the incidence and severity of catastrophes, both natural and man-made; the possible occurrence of terrorist attacks; stronger than anticipated competitive activity; unfavorable judicial or legislative developments; the potential effect of regulatory developments, including those which could increase the Company’s business costs and required capital levels; the Company’s ability to distribute its products through distribution channels, both current and future; the uncertain effect of emerging claim and coverage issues; the effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements; information technology system failures or network disruptions; risks related to cybersecurity matters, such as breaches of our computer network or those of other parties or the loss of or unauthorized access to the data we maintain; and those other risks and uncertainties detailed in statements and reports that the Company files from time to time with the Securities and Exchange Commission. As a result, undue reliance should not be placed upon forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to publicly update any forward-looking statements as a result of subsequent developments, changes in underlying assumptions or facts or otherwise, except as may be required by law.
| For further information contact: | |
| J. Ross Franklin | Hilton H. Howell, Jr. |
| Chief Financial Officer | Chairman, President & CEO |
| Atlantic American Corporation | Atlantic American Corporation |
| 404-266-5580 | 404-266-5505 |
| Atlantic American Corporation Financial Data | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| September 30, | September 30, | ||||||||||||||
| (Unaudited; In thousands, except per share data) | 2025 | 2024 | 2025 | 2024 | |||||||||||
| Insurance premiums | |||||||||||||||
| Life and health | $ | 29,472 | $ | 27,568 | $ | 87,059 | $ | 81,691 | |||||||
| Property and casualty | 22,500 | 16,214 | 61,972 | 51,636 | |||||||||||
| Insurance premiums, net | 51,972 | 43,782 | 149,031 | 133,327 | |||||||||||
| Net investment income | 2,633 | 2,477 | 7,591 | 7,449 | |||||||||||
| Realized investment gains, net | 2 | 4 | 18 | 17 | |||||||||||
| Unrealized gains (losses) on equity securities, net | (848 | ) | (1,746 | ) | 2,528 | (1,617 | ) | ||||||||
| Other income | 1 | 2 | 7 | 8 | |||||||||||
| Total revenue | 53,760 | 44,519 | 159,175 | 139,184 | |||||||||||
| Insurance benefits and losses incurred | |||||||||||||||
| Life and health | 17,509 | 16,776 | 52,459 | 53,467 | |||||||||||
| Property and casualty | 17,962 | 13,984 | 48,572 | 41,025 | |||||||||||
| Insurance benefits and losses incurred, net | 35,471 | 30,760 | 101,031 | 94,492 | |||||||||||
| Commissions and underwriting expenses | 12,955 | 11,490 | 37,505 | 35,740 | |||||||||||
| Interest expense | 779 | 869 | 2,326 | 2,591 | |||||||||||
| Other expense | 3,786 | 3,854 | 12,293 | 12,170 | |||||||||||
| Total benefits and expenses | 52,991 | 46,973 | 153,155 | 144,993 | |||||||||||
| Income (loss) before income taxes | 769 | (2,454 | ) | 6,020 | (5,809 | ) | |||||||||
| Income tax expense (benefit) | 192 | (456 | ) | 1,325 | (1,129 | ) | |||||||||
| Net income (loss) | $ | 577 | $ | (1,998 | ) | $ | 4,695 | $ | (4,680 | ) | |||||
| Earnings (loss) per common share (basic) | $ | 0.02 | $ | (0.10 | ) | $ | 0.22 | $ | (0.24 | ) | |||||
| Earnings (loss) per common share (diluted) | $ | 0.02 | $ | (0.10 | ) | $ | 0.22 | $ | (0.24 | ) | |||||
| Reconciliation of non-GAAP financial measure | |||||||||||||||
| Net income (loss) | $ | 577 | $ | (1,998 | ) | $ | 4,695 | $ | (4,680 | ) | |||||
| Income tax expense (benefit) | 192 | (456 | ) | 1,325 | (1,129 | ) | |||||||||
| Realized investment gains, net | (2 | ) | (4 | ) | (18 | ) | (17 | ) | |||||||
| Unrealized (gains) losses on equity securities, net | 848 | 1,746 | (2,528 | ) | 1,617 | ||||||||||
| Non-GAAP operating income (loss) | $ | 1,615 | $ | (712 | ) | $ | 3,474 | $ | (4,209 | ) | |||||
| September 30, | December 31, | ||||||||||||||
| Selected balance sheet data | 2025 | 2024 | |||||||||||||
| Total cash and investments | $ | 289,514 | $ | 265,696 | |||||||||||
| Insurance subsidiaries | 283,380 | 258,675 | |||||||||||||
| Parent and other | 6,134 | 7,021 | |||||||||||||
| Total assets | 430,855 | 393,428 | |||||||||||||
| Insurance reserves and policyholder funds | 249,578 | 225,106 | |||||||||||||
| Debt | 37,759 | 37,761 | |||||||||||||
| Total shareholders' equity | 109,488 | 99,613 | |||||||||||||
| Book value per common share | 5.10 | 4.61 | |||||||||||||
| Statutory capital and surplus | |||||||||||||||
| Life and health | 34,552 | 32,443 | |||||||||||||
| Property and casualty | 48,161 | 47,670 | |||||||||||||